InnovAge (NASDAQ:INNV – Get Free Report) announced its earnings results on Tuesday. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.04), Zacks reports. The company had revenue of $205.14 million during the quarter, compared to analysts’ expectations of $203.35 million. InnovAge had a negative net margin of 2.79% and a negative return on equity of 7.43%. During the same quarter in the previous year, the business posted ($0.08) earnings per share. InnovAge updated its FY 2025 guidance to EPS.
InnovAge Price Performance
INNV stock traded up $0.04 during midday trading on Friday, reaching $6.10. The company had a trading volume of 17,106 shares, compared to its average volume of 37,092. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.25 and a quick ratio of 1.25. The company has a market capitalization of $826.55 million, a price-to-earnings ratio of -37.88 and a beta of 0.39. InnovAge has a 1-year low of $3.52 and a 1-year high of $6.69. The stock has a 50 day moving average price of $5.92 and a 200-day moving average price of $5.37.
Analyst Upgrades and Downgrades
Separately, KeyCorp started coverage on shares of InnovAge in a research report on Friday, October 11th. They issued a “sector weight” rating for the company.
Insiders Place Their Bets
In other InnovAge news, insider Nicole Damato sold 4,372 shares of the business’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $5.95, for a total transaction of $26,013.40. Following the completion of the transaction, the insider now owns 240,795 shares of the company’s stock, valued at approximately $1,432,730.25. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.40% of the company’s stock.
About InnovAge
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
Recommended Stories
- Five stocks we like better than InnovAge
- 5 Top Rated Dividend Stocks to Consider
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Investing in Travel Stocks Benefits
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.